Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Although the prognosis in malignant resectable intraductal papillary mucinous tumours of the pancreas (IPMT) is often considered more favourable than for ordinary pancreatic ductal adenocarcinoma, the long term outcome remains ill defined. AIMS: To assess prognostic factors in patients with malignant IPMT after surgical resection, and to compare long term survival rates with those of patients surgically treated for ductal adenocarcinoma. METHODS: Seventy three patients underwent surgery for malignant IPMT in four French centres. Clinical, biochemical, and pathological features and follow up after resection were recorded. Patients with invasive malignant IPMT were matched with patients with pancreatic ductal adenocarcinoma, according to age and TNM stages; survival rates after resection were compared. RESULTS: Surgical treatment for IPMT were pancreaticoduodenectomy (n=46), distal (n=14), total (n=11), or segmentary (n=2) pancreatectomy. The operative mortality rate was 4%. IPMT corresponded to in situ (n=22) or invasive carcinoma (n=51). In the latter group, 17 had lymph node metastases. Overall median survival was 47 months. Five year survival rates in patients with in situ and invasive carcinoma were 88% and 36%, respectively. On univariate analysis, abdominal pain, preoperative high serum carbohydrate antigen 19.9 concentrations, caudal localisation, invasive carcinoma, lymph node metastases, peripancreatic extension, and malignant relapse were associated with a fatal outcome. Using multivariate analysis, lymph node metastases were the only prognostic factor (OR 7.5; 95% CI: 3.4 to 16.4). Overall five year survival rate was higher in patients with malignant invasive IPMT compared with those with pancreatic ductal carcinoma (36 v 21%, p=0.03), but was similar in the subset of stage II/III tumours. CONCLUSIONS: The prognosis of patients with resected in situ/invasive stage I malignant IPMT is excellent. In contrast, prognosis of locally advanced forms is as poor as in patients with pancreatic ductal adenocarcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
International Histological Classification of Tumours
Weller, R. (1981) · Journal of Clinical Pathology · doi:10.1136/jcp.34.6.692-d · Cited by 2,042
Conlon, K. C., Klimstra, D. S., & Brennan, M. F. (1996) · Annals of Surgery · doi:10.1097/00000658-199603000-00007 · Cited by 709
Pedrazzoli, S., DiCarlo, V., Dionigi, R., Mosca, F., Pederzoli, P., Pasquali, C., Klöppel, G., Dhaene, K., & Michelassi, F. (1998) · Annals of Surgery · doi:10.1097/00000658-199810000-00007 · Cited by 692
Long-Term Survival After Resection for Ductal Adenocarcinoma of the Pancreas Is It Really Improving?
Nitecki, S. S., Sarr, M. G., Colby, T. V., & van Heerden, J. A. (1995) · Annals of Surgery · doi:10.1097/00000658-199501000-00007 · Cited by 586
Intraductal papillary mucinous tumors of the pancreas
Nakagohri, T., Kenmochi, T., Kainuma, O., Tokoro, Y., & Asano, T. (1999) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)00192-0 · Cited by 542
Histological Typing of Tumours of the Exocrine Pancreas
Klöppel, G., Solcia, E., Sobin, L. H., Longnecker, D. S., & Capella, C. (1996) · Springer eBooks · doi:10.1007/978-3-642-61024-0 · Cited by 450
Terris, B., Ponsot, P., Paye, F., Hammel, P., Sauvanet, A., Molas, G., Bernades, P., Belghiti, J., Ruszniewski, P., & Fléjou, J. F. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200010000-00006 · Cited by 420
Loftus, E., Olivares-Pakzad, B., Batts, K., Adkins, M., Stephens, D., Sarr, M., & DiMagno, E. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8964418 · Cited by 353
Kobari, M. (1999) · Archives of Surgery · doi:10.1001/archsurg.134.10.1131 · Cited by 323
Cited by
International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas
Tanaka, M., Fernández-del Castillo, C., Adsay, V., Chari, S., Falconi, M., Jang, J.-Y., Kimura, W., Levy, P., Pitman, M. B., Schmidt, C. M., et al. (2012) · Pancreatology · doi:10.1016/j.pan.2012.04.004 · Cited by 2,354
“However, in cases of stage II/III invasive IPMN, the prognosis is similar to that of PDAC [16,182,183].”
ResultEuropean evidence-based guidelines on pancreatic cystic neoplasms
The European Study Group on Cystic Tumours of the Pancreas (2018) · Gut · doi:10.1136/gutjnl-2018-316027 · Cited by 1,417
Hruban, R. H., Takaori, K., Klimstra, D. S., Adsay, N. V., Albores-Saavedra, J., Biankin, A. V., Biankin, S. A., Compton, C., Fukushima, N., Furukawa, T., et al. (2004) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000126675.59108.80 · Cited by 1,091
Intraductal Papillary Mucinous Neoplasms of the Pancreas: An Updated Experience
Sohn, T. A., Yeo, C. J., Cameron, J. L., Hruban, R. H., Fukushima, N., Campbell, K. A., & Lillemoe, K. D. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000128306.90650.aa · Cited by 874
The role of stroma in pancreatic cancer: Diagnostic and therapeutic implications
Erkan, M., Hausmann, S., Michalski, C. W., Fingerle, A. A., Dobritz, M., Kleeff, J., & Friess, H. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.115 · Cited by 662
Intraductal papillary mucinous tumors of the pancreas
Nakagohri, T., Kenmochi, T., Kainuma, O., Tokoro, Y., & Asano, T. (1999) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)00192-0 · Cited by 542
Scheiman, J. M., Hwang, J. H., & Moayyedi, P. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.01.014 · Cited by 437
Pancreatic Cancer Surgery in the New Millennium: Better Prediction of Outcome
Hartwig, W., Hackert, T., Hinz, U., Gluth, A., Bergmann, F., Strobel, O., Büchler, M. W., & Werner, J. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e31821fd334 · Cited by 412
Mino-Kenudson, M., Fernández-del Castillo, C., Baba, Y., Valsangkar, N. P., Liss, A. S., Hsu, M., Correa-Gallego, C., Ingkakul, T., Perez Johnston, R., Turner, B. G., et al. (2011) · Gut · doi:10.1136/gut.2010.232272 · Cited by 293
Differences in Survival by Histologic Type of Pancreatic Cancer
Fesinmeyer, M. D., Austin, M. A., Li, C. I., De Roos, A. J., & Bowen, D. J. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0120 · Cited by 270
Pelaez-Luna, M., Chari, S. T., Smyrk, T. C., Takahashi, N., Clain, J. E., Levy, M. J., Pearson, R. K., Petersen, B. T., Topazian, M. D., Vege, S. S., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01224.x · Cited by 257
Shin, S. H., Kim, S. C., Hong, S.-M., Kim, Y. H., Song, K.-B., Park, K.-M., & Lee, Y.-J. (2013) · Pancreas · doi:10.1097/mpa.0b013e31825b6ab0 · Cited by 107
Chen, R., Pan, S., Ottenhof, N. A., de Wilde, R. F., Wolfgang, C. L., Lane, Z., Post, J., Bronner, M. P., Willmann, J. K., Maitra, A., et al. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.20842 · Cited by 62
Metadata
- Authors
- Maire, F.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2002-11-01
- Volume
- 51
- Issue
- 5
- Pages
- 717-722
- ISSN
- 0017-5749 (ISSN-L)
- OpenAlex
- W2146710224
- Cited by
- 275
- References
- 22
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.